IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 445,000$2,024,7500.68%
Logos Global Management LP 1,000,000$4,550,0000.61%
Soleus Capital Management, L.P. 1,239,777$5,640,9850.52%
RICE HALL JAMES & ASSOCIATES, LLC 1,722,711$7,838,3350.50%
Avoro Capital Advisors LLC 6,700,000$30,485,0000.48%
Rhenman & Partners Asset Management AB 950,000$4,322,5000.47%
Orbimed Advisors 4,707,458$21,418,9340.46%
Long Focus Capital Management, LLC 2,470,521$11,240,8710.40%
Vivo Capital, LLC 655,057$2,980,5090.33%
Hood River Capital Management LLC 1,992,335$9,065,1240.29%
External links

This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q3 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.